Dashboard
Manage Tickers

KVUE Kenvue Inc.

NYSE www.jnj.com/kenvue/


$ 15.31 $ 1.18 (8.36 %)    

Friday, 17-Oct-2025 19:55:22 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 15.29
$ 14.26
$ 15.27 x 10
$ 15.40 x 100
$ 14.22 - $ 15.58
$ 14.05 - $ 24.72
51,896,460
na
29.34B
$ 0.90
$ 20.69
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-29-2025 10-Q
2 05-08-2025 03-30-2025 10-Q
3 02-24-2025 12-29-2024 10-K
4 11-07-2024 09-29-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-01-2024 12-31-2023 10-K
8 11-03-2023 10-01-2023 10-Q
9 08-02-2023 07-02-2023 10-Q
10 06-02-2023 04-02-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

revolution-medicines-disc-medicine-american-express-and-other-big-stocks-moving-higher-on-friday
Revolution Medicines, Disc Medicine, Ameri...
10/17/2025 16:02:18

Core News & Articles
Reported Earlier: 'J&J Faces First UK Laws...
10/16/2025 15:25:41

https://www.reuters.com/sustainability/boards-policy-regulation/jj-faces-first-uk-lawsuits-alleging-its-baby-powder-caused-canc...

johnson--johnson-kenvue-named-in-first-ever-uk-legal-action-over-talc-cancer-claims
Johnson & Johnson, Kenvue Named In First E...
10/16/2025 14:18:35

Johnson & Johnson faces 3,000 UK lawsuits alleging asbestos-contaminated talcum powder caused cancer and concealed risks fo...

kenvue-and-albert-invent-partner-to-accelerate-global-rd-with-ai-powered-product-development-platform
Kenvue And Albert Invent Partner To Accele...
10/14/2025 16:07:59

Frontier AI company Albert Invent today announced a strategic partnership with Kenvue Inc. (NYSE:KVUE), maker of consumer healt...

johnson--johnson-q3-preview-with-stock-near-all-time-highs-heres-what-to-watch
Johnson & Johnson Q3 Preview: With Stock N...
10/13/2025 16:27:44

Johnson & Johnson stock trades near all-time highs with an upcoming Q3 earnings report acting as the next catalyst.

tylenol-turmoil-partisan-politics-fuel-confusion-over-pregnancy-risks-poll-shows
Tylenol Turmoil: Partisan Politics Fuel Co...
10/10/2025 17:24:22

KFF poll shows falling trust in the CDC and HHS chief RFK Jr. as misinformation and partisan divides shape public views on vacc...

jp-morgan-maintains-overweight-on-kenvue-lowers-price-target-to-21
JP Morgan Maintains Overweight on Kenvue, ...
10/10/2025 13:22:51

JP Morgan analyst Andrea Teixeira maintains Kenvue (NYSE:KVUE) with a Overweight and lowers the price target from $24 to $21.

stocks-ease-delta-air-lines-pepsi-jump-on-strong-earnings-whats-moving-markets-thursday
Stocks Ease, Delta Air Lines, Pepsi Jump O...
10/09/2025 17:53:50

U.S. stocks edged lower on Thursday, pausing after a record-setting run. The S&P 500 slipped 0.4% by midday in New York, re...

citigroup-maintains-neutral-on-kenvue-lowers-price-target-to-17
Citigroup Maintains Neutral on Kenvue, Low...
10/09/2025 16:30:49

Citigroup analyst Filippo Falorni maintains Kenvue (NYSE:KVUE) with a Neutral and lowers the price target from $20 to $17.

b-of-a-securities-maintains-buy-on-kenvue-lowers-price-target-to-21
B of A Securities Maintains Buy on Kenvue,...
10/08/2025 18:03:27

B of A Securities analyst Anna Lizzul maintains Kenvue (NYSE:KVUE) with a Buy and lowers the price target from $25 to $21.

ubs-maintains-neutral-on-kenvue-lowers-price-target-to-17
UBS Maintains Neutral on Kenvue, Lowers Pr...
10/08/2025 16:22:17

UBS analyst Peter Grom maintains Kenvue (NYSE:KVUE) with a Neutral and lowers the price target from $23 to $17.

stocks-bitcoin-slip-gold-hits-4000-whats-moving-markets-tuesday
Stocks, Bitcoin Slip, Gold Hits $4,000: Wh...
10/07/2025 17:39:09

Risk sentiment is taking a breather after days of a relentless rally, with all major Wall Street indexes trading in negative te...

options-corner-despite-political-woes-kenvue-can-still-make-tylenol-great-again
Options Corner: Despite Political Woes, Ke...
10/06/2025 19:22:41

While Kenvue's Tylenol has attracted intense political pressure, speculators are determined to make KVUE stock great again.

Core News & Articles
A Congress Member Sold Up To $330K In Unit...
10/06/2025 15:00:30

goldman-sachs-maintains-neutral-on-kenvue-lowers-price-target-to-19
Goldman Sachs Maintains Neutral on Kenvue,...
10/02/2025 17:35:36

Goldman Sachs analyst Bonnie Herzog maintains Kenvue (NYSE:KVUE) with a Neutral and lowers the price target from $22 to $19.

barclays-maintains-equal-weight-on-kenvue-lowers-price-target-to-17
Barclays Maintains Equal-Weight on Kenvue,...
10/01/2025 15:15:11

Barclays analyst Lauren Lieberman maintains Kenvue (NYSE:KVUE) with a Equal-Weight and lowers the price target from $20 to $17.

Core News & Articles
President Trump On Truth Social Says Pregn...
09/26/2025 14:50:46

https://truthsocial.com/@realDonaldTrump/posts/115271135823530018

demystifying-kenvue-insights-from-11-analyst-reviews
Demystifying Kenvue: Insights From 11 Anal...
09/26/2025 12:01:53

Kenvue (NYSE: KVUE) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to b...

rothschild--co-upgrades-kenvue-to-buy-lowers-price-target-to-22
Rothschild & Co Upgrades Kenvue to Buy, Lo...
09/26/2025 11:37:48

Rothschild & Co analyst Edward Lewis upgrades Kenvue (NYSE: KVUE) from Neutral to Buy and lowers the price target from $...

white-house-highlights-a-controversial-2017-tylenol-tweet-on-its-usage-during-pregnancy-we-actually-dont-recommend
White House Highlights A Controversial 201...
09/26/2025 09:55:18

A 2017 post by Tylenol on X (formerly Twitter) highlighted by White House has fueled a buzz around President Donald Trump‘s cla...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION